Skip to content

D&A at other companies

TFX
TeleflexTFX
$19.85M+52.3%
Boston Scientific logo
Boston ScientificBSX
$351M+8.0%
Absci Corporation logo
Absci CorporationABSI
$2.73M-11.2%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$10.4M+14.3%
iRadimed logo
iRadimedIRMD
$455K+135%
Novanta logo
NovantaNOVT
$14.16M+4.4%

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-22.5%
Enterprise value$1.25B
P/S3.7×

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's D&A?
PROCEPT BioRobotics Corporation (PRCT) reported D&A of $1.74M in Q1 2026.
How has PROCEPT BioRobotics Corporation's D&A changed year-over-year?
PROCEPT BioRobotics Corporation's D&A increased by 17.6% year-over-year, from $1.48M to $1.74M.
What is the long-term trend for PROCEPT BioRobotics Corporation's D&A?
Over 4 years (2021 to 2025), PROCEPT BioRobotics Corporation's D&A has grown at a 17.7% compound annual growth rate (CAGR), from $3.32M to $6.39M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.